VolitionRX Limited (VNRX)
(Real Time Quote from BATS)
$0.66 USD
+0.03 (3.94%)
Updated Sep 20, 2024 03:19 PM ET
NA Value
NA Growth NA Momentum NA VGMBalance Sheet
Fiscal Year End for VolitionRX Limited falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 21 | 11 | 21 | 19 | 17 |
Receivables | 0 | 0 | 0 | 0 | 0 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Other Current Assets | 1 | 1 | 1 | 1 | 1 |
Total Current Assets | 22 | 12 | 22 | 20 | 18 |
Net Property & Equipment | 6 | 5 | 5 | 5 | 3 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 0 | 0 | 0 | 0 | 0 |
Deposits & Other Assets | 0 | 0 | 0 | 0 | 0 |
Total Assets | 28 | 18 | 27 | 26 | 21 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 3 | 3 | 2 | 2 | 1 |
Current Portion Long-Term Debt | 1 | 1 | 1 | 1 | 1 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 4 | 3 | 4 | 3 | 2 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 23 | 10 | 0 | 0 | 0 |
Total Current Liabilities | 32 | 17 | 7 | 6 | 4 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 4 | 3 | 2 | 3 | 2 |
Non-Current Capital Leases | 0 | 0 | 1 | 1 | 1 |
Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 37 | 21 | 10 | 10 | 7 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 194 | 164 | 155 | 127 | 104 |
Retained Earnings | -203 | -167 | -137 | -110 | -90 |
Other Equity | -1 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | -9 | -3 | 18 | 16 | 14 |
Total Liabilities & Shareholder's Equity | 28 | 18 | 27 | 26 | 21 |
Total Common Equity | -9 | -3 | 18 | 16 | 14 |
Shares Outstanding | 78.60 | 57.50 | 53.50 | 48.20 | 41.00 |
Book Value Per Share | -0.11 | -0.05 | 0.33 | 0.34 | 0.35 |
Fiscal Year End for VolitionRX Limited falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 6 | 12 | 21 | 11 | 20 |
Receivables | 0 | 0 | 0 | 0 | 0 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Other Current Assets | 1 | 2 | 1 | 1 | 2 |
Total Current Assets | 7 | 13 | 22 | 12 | 22 |
Net Property & Equipment | 5 | 5 | 6 | 5 | 5 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 0 | 0 | 0 | 0 | 0 |
Deposits & Other Assets | 0 | 0 | 0 | 0 | 0 |
Total Assets | 13 | 19 | 28 | 18 | 28 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 3 | 4 | 3 | 3 | 3 |
Current Portion Long-Term Debt | 1 | 1 | 1 | 1 | 1 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 3 | 3 | 4 | 3 | 3 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 23 | 23 | 23 | 10 | 10 |
Total Current Liabilities | 31 | 31 | 32 | 18 | 19 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 4 | 3 | 4 | 2 | 2 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 0 | 0 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 36 | 36 | 37 | 21 | 22 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 196 | 195 | 194 | 192 | 191 |
Retained Earnings | -218 | -211 | -203 | -194 | -186 |
Other Equity | -1 | -1 | -1 | -1 | -1 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | -23 | -17 | -9 | -3 | 5 |
Total Liabilities & Shareholder's Equity | 13 | 19 | 28 | 18 | 28 |
Total Common Equity | -23 | -17 | -9 | -3 | 5 |
Shares Outstanding | 82.90 | 82.00 | 78.60 | 78.10 | 63.10 |
Book Value Per Share | -0.28 | -0.20 | -0.11 | -0.04 | 0.08 |